Pridgen William 4
4 · Virios Therapeutics, Inc. · Filed Mar 24, 2022
Insider Transaction Report
Form 4
Pridgen William
Director
Transactions
- Purchase
Common Stock
2022-03-23$5.46/sh+2,197$12,002→ 22,419 total(indirect: 401 (k) Account)
Holdings
- 709,234
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.37 to $5.48, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]Reflects corrected holdings, as prior reports incorrectly understated indirect holdings and overstated direct holdings, by 1,500 shares.
- [F3]The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.